{"nctId":"NCT02111798","briefTitle":"Bupropion-Enhanced Contingency Management (CM) for Cocaine Dependence","startDateStruct":{"date":"2014-07"},"conditions":["Substance Abuse","Cocaine Dependence"],"count":83,"armGroups":[{"label":"Placebo/Abstinence Initiation","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo","Behavioral: Abstinence Initiation"]},{"label":"Bupropion XL/Abstinence Initiation","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Bupropion XL","Behavioral: Abstinence Initiation"]},{"label":"Placebo/Relapse Prevention","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo","Behavioral: Relapse Prevention"]},{"label":"Bupropion XL/Relapse Prevention","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Bupropion XL","Behavioral: Relapse Prevention"]}],"interventions":[{"name":"Placebo","otherNames":[]},{"name":"Bupropion XL","otherNames":[]},{"name":"Abstinence Initiation","otherNames":[]},{"name":"Relapse Prevention","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Enrolled in methadone maintenance\n* Meets Diagnostic and Statistical Manual of Mental Disorders, Fifth edition (DSM V) criteria for active cocaine use\n* Submits one cocaine positive urine sample within 30 days of study start\n* Agrees to study procedures\n\nExclusion Criteria:\n\n* Healthy and without contra-indications to study medication\n* Any history of epilepsy or seizure, including alcohol-, sedative-, or cocaine-related seizure\n* Any increased risk of seizure such as serious head trauma with a loss of consciousness of more than an hour duration, brain tumor, or other brain pathology increasing risk of seizure.\n* Current eating disorder including anorexia or bulimia\n* Current use (last 30 days) of antidepressants, antipsychotics, theophyllines, systemic steroids, monoamine oxidase (MAO-A) inhibitors.\n* Recent use (last 30 days) of budeprion, zyban®, wellbutrin®, aplenzin®, or any other medication containing bupropion.\n* Allergy to bupropion or budeprion\n* Liver enzymes greater than 3x ULN (upper limit of normal)\n* Uncontrolled diabetes mellitus, or h/o diabetic coma\n* Uncontrolled hypertension with BP \\> 140/90.\n* Current psychiatric diagnosis: schizophrenia, psychosis, major depression, mania, current suicidal ideation as determined by MINI psychiatric interview, cognitive impairment severe enough to preclude informed consent or valid responses on questionnaires\n* Severe renal insufficiency (eGFR \\< 30 ml/min)\n* Pregnancy or current breast feeding,\n* Medical illness that in the view of the investigators would compromise participation in research, such as uncompensated congestive heart failure, recent history of myocardial infarction (\\<1year), or urologic conditions that inhibit urine collection.\n* Advanced HIV infection requiring the use of HAART (Highly Active Anti-Retroviral Therapy), or with CD4 T cell count \\< 200/uL","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Cocaine Negative Urines","description":"Comparison of the number of thrice-weekly urine tests submitted during weeks study 7-30 negative for cocaine for persons randomly assigned to receive placebo or bupropion XL during weeks 7-30; excused samples are omitted and missing samples are treated as positive.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"70.6","spread":".01"},{"groupId":"OG001","value":"57.7","spread":".01"},{"groupId":"OG002","value":"4.2","spread":".01"},{"groupId":"OG003","value":"14.5","spread":".01"}]}]}]},{"type":"SECONDARY","title":"Longest Consecutive Period of Negative Urine Samples","description":"Comparison of the longest string of urine samples testing negative for cocaine that were submitted at thrice weekly visits between weeks 7-30 from persons who were randomly assigned to receive placebo or bupropion XL; samples that were excused are omitted otherwise missing samples are treated as positive.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.8","spread":"2.0"},{"groupId":"OG001","value":"11.25","spread":"3.3"},{"groupId":"OG002","value":"52.9","spread":"7.0"},{"groupId":"OG003","value":"33.3","spread":"7.2"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":31},"commonTop":["Headache","Depression","Abdominal Pain","Abdominal Cramps","Vomiting"]}}}